Jaguar Health (JAGX) Payables (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Payables data on file, last reported at $27.0 million in Q1 2026.

• Payables for Q1 2026 came in at $27.0 million, up 5.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.0 million (up 5.34% YoY), and the FY2025 annual result was $36.1 million, up 108.53% from the prior year.
• Payables retreated to $27.0 million in Q1 2026 per JAGX's latest filing, from $36.1 million in the prior quarter.
• Over five years, Payables peaked at $36.1 million in Q4 2025 and troughed at $8.6 million in Q3 2023.
• A 5-year average of $19.4 million and a median of $18.0 million in 2022 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2023: Payables soared 223.73% in 2022, then sank 54.63% in 2023.
• A 5-year view of Payables shows it stood at $21.7 million in 2022, then slumped by 54.63% to $9.8 million in 2023, then jumped by 76.04% to $17.3 million in 2024, then jumped by 108.53% to $36.1 million in 2025, then fell by 25.17% to $27.0 million in 2026.
• Business Quant data shows JAGX's Payables at $27.0 million in Q1 2026, $36.1 million in Q4 2025, and $31.6 million in Q3 2025.